Skip to content

uniQure QURE Liability From Royalty Financing Agreement Non Current

Liability From Royalty Financing Agreement Non Current at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.02B+9.3%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$100M0.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$305.04M+22.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$1.13B+42.1%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$557.77M+4.0%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$60.27M-30.2%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.09B+78.4%
Enterprise value$3.02B+124%
P/S170.9×+85.1×

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept qure:LiabilityFromRoyaltyFinancingAgreementNonCurrent.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's liability from royalty financing agreement non current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's liability from royalty financing agreement non current?
uniQure (QURE) reported liability from royalty financing agreement non current of $482.33M in Q1 2026.
How has uniQure's liability from royalty financing agreement non current changed year-over-year?
uniQure's liability from royalty financing agreement non current increased by 8.0% year-over-year, from $446.66M to $482.33M.
What is the long-term trend for uniQure's liability from royalty financing agreement non current?
Over 2 years (2023 to 2025), uniQure's liability from royalty financing agreement non current has grown at a 9.6% compound annual growth rate (CAGR), from $394.24M to $473.2M.
What does liability from royalty financing agreement non current mean?
This reflects the long-term portion of obligations arising from financing arrangements where the company receives upfront capital in exchange for future royalty payments on product sales. It represents a form of non-dilutive financing that creates a long-term claim against future revenue streams. Investors monitor this to evaluate the company's leverage and the impact of future royalty obligations on long-term profitability.